Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model.
Oncotarget
; 9(18): 14042-14057, 2018 Mar 06.
Article
in En
| MEDLINE
| ID: mdl-29581825
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Oncotarget
Year:
2018
Document type:
Article
Affiliation country:
Japan